In non-small cell lung carcinoma, luteolin induced G2/M cell cycle arrest and reduced EMT by reducing the expression of absent in melanoma 2 (AIM2), leading to decreased AIM2 inflammasome activation which was also seen in lung cancer mouse xenograft models [376]. Here, AIM2 is linked to lung cancer.